C—SFD6000F 便攜式升降工作燈
本公司研制開發(fā)生產(chǎn)的SFD6000F型便攜式升降工作燈,適用于各種大型施工作業(yè)、維護(hù)搶修、事故處理和搶險(xiǎn)救災(zāi)等工作現(xiàn)場(chǎng)對(duì)大面積、高亮度照明的需要 照明亮度 大范圍,高亮度,射程遠(yuǎn),燈泡壽命長(zhǎng),燈盤由兩盞150W金鹵燈燈頭組成,平均使用壽命在10000小時(shí)以上。聚光和泛光兩種照明功能可隨意轉(zhuǎn)換,并能在上下較大范圍內(nèi)調(diào)節(jié)照明角度,聚光照射距離達(dá)150m以上。
照射范圍 燈具采用三節(jié)伸縮氣桿作為升降調(diào)節(jié)方式,最大升起高度2.8米;每盞燈可單獨(dú)做上下、左右調(diào)節(jié),整個(gè)燈盤以伸縮氣桿為軸心做360°水平旋轉(zhuǎn)。使用發(fā)電機(jī)組供電時(shí),一次注滿燃油可連續(xù)照明 6小時(shí)以上;使用220V市電可以實(shí)現(xiàn)長(zhǎng)時(shí)間連續(xù)照明。
操作方便 靈活控制每盞燈的開啟和關(guān)閉,使用手動(dòng)可快速控制伸縮氣桿的升降。燈具由燈架(包括燈盤、伸縮氣桿)和發(fā)電機(jī)座(包括發(fā)電機(jī)組、電器箱、發(fā)電機(jī)底座)上下兩部分組成,輕便并易于組合、拆卸,操作簡(jiǎn)單,實(shí)用方便。
使用環(huán)境 采用多重防震結(jié)構(gòu)設(shè)計(jì),抗震性能,能在各種高頻震動(dòng)環(huán)境中使用。采用符合環(huán)保的輕質(zhì)合金材料和高科技噴涂技術(shù),防塵防水,耐腐防銹,適合在戶外工作。良好的電磁兼容性,不會(huì)對(duì)輸電網(wǎng)絡(luò)造成干擾。燈具整體采用進(jìn)口金屬材料制作,質(zhì)量穩(wěn)定,性能,能在惡劣環(huán)境和氣候條件下正常工作。
為您定制 為滿足用戶個(gè)性化的需求,如本產(chǎn)品的標(biāo)準(zhǔn)配置不能滿足用戶的工作需要,我司可在燈盤的燈頭數(shù)量、功率、泛光或聚光類型、伸縮氣桿升起的高度及發(fā)電機(jī)的功率上按用戶要求做出調(diào)整。
ATM卡號(hào)疊加器,ATM卡號(hào)捕獲器,ATM卡號(hào)獲取模塊CD-80
卡號(hào)捕捉設(shè)備
1.有了卡號(hào)疊加的ATM監(jiān)控錄像,就能充分證明“就是這個(gè)人,拿了這張卡,取了這筆錢”,因?yàn)槠渌涗浀膱D像上不僅有人像,出鈔的錢,還有卡號(hào),它已經(jīng)將人和卡緊密地結(jié)合起來。首先,在哪個(gè)賬上取了錢,是由ATM機(jī)記錄的,而記錄誰取了錢是由ATM監(jiān)控系統(tǒng)(DVR)記錄的,因此取錢的賬號(hào)與取錢的人沒有必然的聯(lián)系,能有關(guān)聯(lián)的就是時(shí)間,但是ATM機(jī)的記錄時(shí)間與DVR的記錄時(shí)間往往相差兩分鐘以上,有了這個(gè)時(shí)間差,就無法作為法庭上的證據(jù)。因?yàn)槲覈F(xiàn)行的法律明文規(guī)定控方必須提供確切的證據(jù),才能判定被告有罪,而無需被告去證明自己無罪,因此沒有卡號(hào)疊加的ATM監(jiān)控將大大削弱其作為監(jiān)控應(yīng)有的功能。另外,ATM監(jiān)控的另一個(gè)作用是為了很好地解決客戶與銀行之間的糾紛。例如:出現(xiàn)ATM機(jī)記賬不吐錢時(shí),一般處理過程是:銀行首先清點(diǎn)錢箱,然后查看ATM取錢記錄,如果多出錢,可查看監(jiān)控錄像,再確定是誰應(yīng)該得到補(bǔ)償。由于錄像中沒有ATM卡號(hào),因此整個(gè)確認(rèn)過程很復(fù)雜,且可能出錯(cuò),這使得儲(chǔ)戶怨聲載道。如果ATM監(jiān)控錄像中疊加有卡號(hào),一切問題的解決就容易多了,只需要查看監(jiān)控錄像,然后以錄像中的卡號(hào)查看ATM記賬情況,立即就可以確認(rèn)銀行應(yīng)向此客戶提供多少補(bǔ)償,使儲(chǔ)戶不至于等上幾天才能解決問題,從而融洽儲(chǔ)戶與銀行之間的關(guān)系。因此,卡號(hào)疊加在ATM監(jiān)控系統(tǒng)中有著非比尋常的意義。
遠(yuǎn)拓科技的安全捕捉ATM卡號(hào)疊加器CD-8081、真正的兩路視頻安全卡號(hào)實(shí)時(shí)識(shí)別疊加技術(shù)視頻疊加時(shí)可以將卡號(hào)、日期、時(shí)間、報(bào)警信息等實(shí)時(shí)疊加到兩路視頻圖像上,擯棄了通道方式,防止了疊加信息被輕易修改。2、綜合信息查詢、兩路同步回放用戶可通過卡號(hào)、日期、時(shí)間、報(bào)警信息等進(jìn)行組合查詢,特別是卡號(hào)查詢?yōu)橛脩籼峁┝藰O大方便。3、偽卡數(shù)據(jù)庫報(bào)警在銀行提供偽卡數(shù)據(jù)的前提下,可建立偽卡數(shù)據(jù)庫,對(duì)正在使用的偽卡進(jìn)行即時(shí)報(bào)警,最大限度的防止犯罪的發(fā)生。二、卡號(hào)捕捉的使用環(huán)境適用ATM機(jī)型 NCR、迪堡、好利獲得、富士通、西門子等主流機(jī)型適用卡型 磁卡及信用卡均可,不限發(fā)行行與ATM主機(jī)接口類型 磁信號(hào)與監(jiān)控主機(jī)接口類型 232、485、PCI 工作電壓 12V工作溫度 +5℃~+50℃;工作濕度 <90%貯存溫度 -20℃~+70℃;貯存濕度 <95%外型尺寸 15×12×4cm
目前市場(chǎng)上的ATM監(jiān)控產(chǎn)品在獲取號(hào)時(shí)所采用的方式主要有五種:
一、 從ATM主機(jī)的串口獲取卡號(hào)信息
該方式通過與ATM機(jī)的串口發(fā)生數(shù)據(jù)通訊,從而獲取卡號(hào)等數(shù)據(jù)信息。
二、 從ATM主機(jī)的并口獲取卡號(hào)信息
三、 與ATM主機(jī)進(jìn)行網(wǎng)絡(luò)通訊獲取卡號(hào)信息
四、 與ATM主機(jī)的流水打印接口通訊,獲取卡號(hào)信息
該方式是通過與ATM主機(jī)的流水打印接口相并聯(lián),獲取流水?dāng)?shù)據(jù)中的卡號(hào)信息;
以上四種獲取號(hào)的方式,雖然實(shí)現(xiàn)的具體方式有所不同,但在實(shí)質(zhì)上卻有一個(gè)共同點(diǎn):均需與ATM主機(jī)進(jìn)行數(shù)據(jù)通訊,在ATM數(shù)據(jù)信息中提取卡號(hào)數(shù)據(jù)。這無疑會(huì)給銀行帶來新的安全隱患,嚴(yán)重威脅銀行和客戶的信息安全,為那些通過與ATM主機(jī)發(fā)生通訊從而竊取、改變甚至控制ATM主機(jī)的高智商犯罪分子提供了條件,違背了ATM監(jiān)控系統(tǒng)的基本保衛(wèi)原則。
通過卡號(hào)捕捉模塊來讀取卡號(hào)信息
這種方式是安裝一個(gè)卡號(hào)捕捉模塊,通過讀卡器獲取卡號(hào)信息,單向讀取卡號(hào),不與ATM機(jī)發(fā)生數(shù)據(jù)交換,對(duì)用戶信息不會(huì)產(chǎn)生威脅
該捕捉模塊只在極其底層的讀卡器上采集客戶卡號(hào)信息,不需要銀行開放ATM軟件,也不會(huì)干擾和采集到客戶的密碼信息,確保了客戶個(gè)人信息的安全,同時(shí)也不會(huì)為銀行帶來新的安全隱患。
該系列儀器的技術(shù)指標(biāo)均滿足國家計(jì)量總局頒布的JJF1190-2008檢定規(guī)程的要求,整機(jī)功能采用美國微電腦控制處理技術(shù)及國際上進(jìn)的SMT芯片貼片封裝技術(shù)和傳感器及氣泵,可直接打印檢測(cè)結(jié)果。具有功能多、測(cè)量精度高、速度快、便于攜帶和操作簡(jiǎn)單等特點(diǎn)。儀器一次采樣可同時(shí)測(cè)得多種粒徑的塵埃粒子數(shù),并能選擇觀察其中某一粒徑粒子的數(shù)目及其變化情況,對(duì)于研究、檢測(cè)和評(píng)價(jià)各種潔凈環(huán)境都十分方便。 該系列儀器性能設(shè)計(jì)、質(zhì)量穩(wěn)定 該系列產(chǎn)品已被廣泛應(yīng)用于潔凈室檢測(cè);過濾器現(xiàn)場(chǎng)檢測(cè)、撿漏;可監(jiān)測(cè)超凈工作臺(tái)、生物安全柜,HVAC系統(tǒng),計(jì)算機(jī)室,飲料包裝環(huán)境,醫(yī)療器械生產(chǎn)環(huán)境,醫(yī)院潔凈手術(shù)室,汽車噴涂環(huán)境微電子、制藥、生化制品、精細(xì)化工、精密機(jī)械和航空航天等生產(chǎn)和科研部門,是制藥企業(yè)及其監(jiān)督管理部門貫徹GMP規(guī)范及電子生產(chǎn)企業(yè)的儀器。
1.光源:普通激光光源
2.采樣量: 2.83L/min(0.1cfm/min)
3.檢測(cè)范圍: 100級(jí)~30萬級(jí)
4.允許被測(cè)試空氣的含塵濃度≯10 萬顆/2.83L
5.粒徑通道: 0.3 0.5 1.0 3.0 5.0 10.0(μm)六檔6.顯示或打印可將2.83升/分內(nèi)所含顆粒轉(zhuǎn)換成1m3所含顆粒數(shù)
7.采樣周期: 1~10 (min)
8.自凈時(shí)間: ≤15 (min)
9.校準(zhǔn):可追溯美國國家標(biāo)準(zhǔn)技術(shù)協(xié)會(huì)(NIST),我公司已通過國家計(jì)量建標(biāo)考核,可追溯至上海計(jì)量測(cè)量技術(shù)研究院可自行進(jìn)行校準(zhǔn)或第三方國家計(jì)量機(jī)構(gòu)進(jìn)行校準(zhǔn)
10.工作環(huán)境: 溫度:10~35℃ 相對(duì)溫度: 20~75%RH
11.最大功耗: 70W
12.測(cè)量溫度和濕度的范圍與精度:(選購)
(1) 溫度:0~50℃±1℃
(2) 濕度:0~100%RH±5%
13.采樣點(diǎn)數(shù) 2~7點(diǎn)設(shè)定
14.每點(diǎn)采樣次數(shù) 2~9次設(shè)定
15.報(bào)告:符合FS-209E、中國GMP的標(biāo)準(zhǔn)
16.工作時(shí)間:8 小時(shí)
17.電源: AC220V±10% 50±2Hz
18.重量: 5.8kg
19.外形尺寸: 260×130×340
20.六檔粒徑塵埃濃度同時(shí)檢測(cè),依次數(shù)字顯示或自選粒徑顯示。
21.備注: 內(nèi)置打印機(jī)、自動(dòng)判斷凈化等級(jí)、等動(dòng)力采樣頭、采樣架(溫濕度探頭為選購件)
LGC是Laboratory of the Government Chemist的簡(jiǎn)稱,中文名英國政府化學(xué)家實(shí)驗(yàn)室,是化學(xué)和生物計(jì)量、法醫(yī)、診斷科學(xué)服務(wù)及標(biāo)準(zhǔn)物質(zhì)方面的市場(chǎng)。作為L(zhǎng)GC的重要分支,LGC標(biāo)準(zhǔn)品有限公司可為測(cè)量科學(xué)和實(shí)驗(yàn)室控制提供一系列產(chǎn)品和服務(wù),包括標(biāo)準(zhǔn)物質(zhì)分銷、組織實(shí)驗(yàn)室水平測(cè)試(Proficiency Test,PT,也即能力測(cè)試)、藥物雜質(zhì)生產(chǎn)及提供特殊合成服務(wù)。LGC(英國政府化學(xué)家實(shí)驗(yàn)室)(中國區(qū)授權(quán)代理)——LGC標(biāo)準(zhǔn)品公司在雜質(zhì)生產(chǎn)、內(nèi)控標(biāo)準(zhǔn)物質(zhì)生產(chǎn)機(jī)提供各種藥典標(biāo)準(zhǔn)物質(zhì)方面已經(jīng)建立了全球性的聲譽(yù)。我們代理了超過2800種LGC雜質(zhì)標(biāo)準(zhǔn)品,滿足實(shí)驗(yàn)科研使用,我們客戶服務(wù)的多項(xiàng)內(nèi)容了我們能向醫(yī)藥客戶提供更具附加值的支持。LGC是目前歐洲最大的雜質(zhì)標(biāo)準(zhǔn)品生產(chǎn)商。貨期2-3周,價(jià)格優(yōu)惠貨期!LGC雜質(zhì)標(biāo)準(zhǔn)品 ----- 英國政府化學(xué)家實(shí)驗(yàn)室(Laboratory of the Government Chemist,簡(jiǎn)稱LGC)。
4-Aminobenzoic Acid 對(duì)氨基苯甲酸 150-13-0 MM 0094.00 Imp. B (EP): Benzocaine 苯唑卡因 94-09-7 (A) 500 mgMM 0093.17 Imp. C (EP) as Hydrochloride: Aniline Hydrochloride 鹽酸苯胺 142-04-1 (B) 100 mgAcebutolol Hydrochloride 鹽酸醋丁洛爾 34381-68-5 MM 0435.00 Acebutolol Hydrochloride 鹽酸醋丁洛爾 34381-68-5 (A) 500 mgMM 0435.01 Imp. A (EP): N-[3-Acetyl-4-[(2RS)-oxiran- (A) 50 mg 2-ylmethoxy]phenyl]butanamide MM 0435.02 Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)- (A) 100 mg 2-hydroxy-3-[(1-methylethyl)amino]- propoxy]phenyl]acetamide Hydrochloride (Diacetolol Hydrochloride) MM 0435.03 Imp. C (EP): N-(3-Acetyl-4-hydroxyphenyl)butanamide (A) 100 mgMM 0435.04 Imp. D (EP) as Hydrochloride: 1-[5-Amino-2- (A) 50 mg [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- propoxy]phenyl]ethanone Dihydrochloride MM 0435.05 Imp. E (EP) as Hydrochloride: N-[4-[(2RS)-2- (A) 50 mg Hydroxy-3-[(1-methylethyl)amino]propoxy]- phenyl]butanamide Hydrochloride MM 0435.06 Imp. F (EP): N-[3-Acetyl-4-[(2RS)- (A) 50 mg 2,3-dihydroxypropoxy]phenyl]butanamide MM 0435.07 Imp. G (EP): N,N'-[[(1-Methylethyl)imino]- (A) 50 mg bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl- 1,4-phenylene)]]dibutanamide (Acebutolol Biamine) MM 0435.08 Imp. H (EP): N,N'-[(2-Hydroxypropane- (A) 50 mg 1,3-diyl)bis[oxy(3-acetyl-1,4-phenylene)]]di- butanamide MM 0435.09 Imp. I (EP): N-[3-Acetyl-4-[(2RS)-3-(ethylamino)- (A) 50 mg 2-hydroxypropoxy]-phenyl]butanamide MM 0435.10 Imp. J (EP) as Hydrochloride: N-[3-Acetyl-4- (A) 50 mg [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]propanamide Hydrochloride MM 0435.11 Imp. K (EP) as Hydrochloride: N-[3-Butanoyl- (A) 50 mg 4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]butanamide Hydrochloride Aceclofenac 醋氯芬酸 89796-99-6 MM 0181.00 Aceclofenac (A) 250 mgMM 0006.20 Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (A) 100 mg (Diclofenac) MM 0006.10 Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (A) 100 mg (Methyl Ester of Diclofenac) MM 0006.11 Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate (A) 100 mg (Ethyl Ester of Diclofenac) MM 0181.01 Imp. D (EP): Methyl [[[2-[(2,6-Dichloro- (A) 100 mg phenyl)amino]phenyl]acetyl]oxy]- acetate (Methyl Ester of Aceclofenac) MM 0181.02 Imp. E (EP): Ethyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl] (A) 100 mg acetyl]oxy]acetate (Ethyl Ester of Aceclofenac) MM 0181.03 Imp. F (EP): ): Benzyl[[[2-[(2,6-Dichlorophenyl)amino]phenyl] (A) 100 mg acetyl]oxy]acetate (Benzyl Ester of Aceclofenac) MM 0181.04 Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]- (A) 100 mg acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac) MM 0006.01 Imp. I (EP):1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one (A) 100 mgMM 0181.05 Imp. H (EP): [[[[[[[2-[(2,6-Dichlorophenyl)- (A) 50 mg amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]-oxy]acetic Acid (Diacetic Aceclofenac) MM 0181.06 Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (A) 100 mg (Isopropyl Ester of Diclofenac) Acetazolamide 乙酰唑胺 59-66-5 MM 0648.00 Acetazolamide (A) 500 mgAcetylcysteine N-乙酰-L-半胱氨酸 616-91-1 MM 0024.00 N-Acetyl-L-cysteine (A) 500 mgMM 0024.03 Imp. A (EP): L-Cystine (B) 100 mgMM 0024.02 Imp. B (EP): L-Cysteine (B) 100 mgMM 0024.04 Imp. C (EP): N,N’-Diacetyl-L-cystine (A) 100 mgMM 0024.01 Imp. D (EP): N,S-Diacetyl-L-cysteine (A) 100 mgMM 0024.05 Sodium 2-Methyl-4,5-dihydro-1,3-thiazol-4-carboxylate (A) 100 mgMM 0024.06 N-Propionyl-L-cysteine (A) 100 mgAcetylsalicylic Acid 鄰乙酰水楊酸 50-78-2 MM 0133.00 Acetylsalicylic Acid (A) 500 mgMM 0045.01 Imp. A (EP): 4-Hydroxybenzoic Acid (B) 100 mgMM 0045.02 Imp. B (EP): 4-Hydroxybenzene-1,3-dicarboxylic Acid (A) 100 mg (4-Hydroxyisophthalic Acid) MM 0045.00 Imp. C (EP): Salicylic Acid (A) 500 mgMM 0133.01 Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (A) 100 mg (Acetylsalicylsalicylic Acid) MM 0133.03 Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (A) 100 mg (Salicylsalicylic Acid) MM 0133.02 Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride (A) 100 mg (Acetylsalicylic Anhydride) MM 0133.04 2-(2,4-Dihydroxybenzoyl)benzoic Acid (A) 100 mgN-Acetyltryptophan N-乙酰-L-色氨酸 1218-34-4 MM 1267.01 Imp. A (EP): Tryptophan (A) 100 mgMM 0172.03 Imp. D (EP): (S)-2-Amino-3-(5-hydroxy- (A) 100 mg 1H-indol-3-yl)propanoic Acid (5-Hydroxy- tryptophan) Aciclovir 阿昔洛韋 59277-89-3 MM 0061.00 Aciclovir (A) 500 mgMM 0061.01 Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin- (A) 100 mg 9-yl)methoxy]ethyl Acetate MM 0061.02 Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine) (B) 100 mgMM 0061.04 Imp. D (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin- (A) 100 mg 9-yl)methoxy]ethyl Benzoate MM 0061.06 Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo- (A) 100 mg 6,9-dihydro-1H-purin-2-yl]acetamide MM 0061.07 Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin- (A) 100 mg 9-yl]methoxy]ethyl Acetate MM 0061.08 Imp. H (EP): 2-[[2-(Acetylamino)-6-oxo-1,6-dihydro-9H- (A) 100 mg purin-9-yl]methoxy]ethyl Benzoate MM 0061.10 2,6-Dichloropurine (B) 100 mgAdenosine 腺苷 58-61-7 MM 0784.00 Adenosine (A) 500 mgAdiphenine Hydrochloride 鹽酸阿地芬寧 50-42-0 MM 1172.00 Adiphenine Hydrochloride (A) 250 mgAdrenaline Tartrate 酒石酸腎上腺素 51-42-3 MM 0614.00 Adrenaline Tartrate (A) 500 mgMM 0614.02 L-Adrenaline (A) 500 mgMM 0614.13 Imp.hydroxyphenyl)-2-(methylamino)ethanoneC (EP) as Hydrochloride: 1-(3,4-Di- (A) 100 mg Hydrochloride (Adrenalone Hydrochloride) MM 0614.01 (1R)-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanesulphonic(Adrenaline ?-Sulphonate) Acid (A) 100 mgAlanine MM 0566.00 Alanine (A) 500 mgAlbendazole 阿苯達(dá)唑 54965-21-8 MM 0382.00 Albendazole (A) 500 mgMM 0382.01 Imp. A (EP): 5-(Propylsulphanyl)-1H-benzimidazol-2-amine (A) 100 mgMM 0382.02 Imp. B (EP): Methyl [5-Propylsulphinyl)-1H-benzimidazol- (A) 100 mg 2-yl]carbamate MM 0382.03 Imp. C (EP): Methyl [5-Propylsulphonyl)-1H-benzimidazol- (A) 100 mg 2-yl]carbamate MM 0382.04 Imp. D (EP): 5-(Propylsulphonyl)-1H-benzimidazol-2-amine (A) 100 mgMM 2500.00 Imp. E (EP): Methyl (1H-Benzimidazol-2-yl)carbamate (A) 100 mg (Carbendazim) Alfuzosin Hydrochloride 鹽酸阿夫唑嗪 81403-68-1 MM 0085.04 Imp. B (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine (A) 100 mgAllobarbital 阿洛巴比妥 52-43-7 MM 0899.00 Allobarbital [Controlled Substance] (A) 100 mgAllopurinol 別嘌醇 315-30-0 MM 0034.00 Allopurinol (A) 500 mgMM 0034.01 Imp. A (EP) as Hemisulphate: 5-Amino-1H-pyrazole- (A) 100 mg 4-carboxamide Hemisulphate MM 0034.05 Imp. D (EP): Ethyl 5-Amino1H-pyrazole-4-carboxylate (A) 100 mgMM 0034.06 Imp. E (EP): Ethyl 5-(Formylamino)-1H-pyrazole-4-carboxylate (A) 100 mgMM 0034.07 Oxypurinol (A) 100 mgAlprazolam 阿普唑侖 28981-97-7 MM 0028.03 Imp. E (EP): (2-Amino-5-chlorophenyl)phenylmethanone (B) 100 mgAlverine Citrate 枸櫞酸阿爾維林 5560-59-8 MM 0454.00 Alverine Citrate (A) 250 mgMM 0454.02 Imp. A (EP): 1-Chloro-3-phenyl-propane (A) 100 mgMM 0454.03 Imp. B (EP): 3-Phenylpropan-1-ol (A) 100 mgMM 0454.04 Imp. C (EP) as Hydrochloride: N-Ethyl- (A) 50 mg 3-phenylpropan-1-amine Hydrochloride MM 0454.05 Imp. D (EP) as Hydrochloride: N-(3- (A) 100 mg Cyclohexylpropyl)-N-ethyl-3-phenyl- propan-1-amine Hydrochloride MM 0454.06 Imp. E (EP) as Hydrochloride: 3-Phenyl- (A) 100 mg N,N-bis(3-phenylpropyl)propan-1-amine Hydrochloride Amantadine Hydrochloride 鹽酸金剛烷胺 665-66-7 MM 0564.00 Amantadine Hydrochloride (A) 500 mgAmbroxol Hydrochloride 鹽酸氨溴索 23828-92-4 MM 0005.00 Ambroxol Hydrochloride (A) 500 mgMM 0005.01 Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol (A) 100 mgMM 0005.04 Imp. B (EP) as Hydrochloride: trans-4-(6,8-Dibromo- (A) 100 mg 1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol Hydrochloride MM 0005.03 Imp. C (EP): trans-4-[[(E)-2-Amino- (A) 100 mg 3,5-dibromobenzyliden]amino]cyclohexanol MM 0005.05 Imp. D (EP) as Hydrochloride: cis-4-[(2-Amino- (A) 100 mg 3,5-dibromobenzyl)amino]cyclohexanol Hydrochloride MM 0005.02 Imp. E (EP): 2-Amino-3,5-dibromobenzaldehyde (A) 100 mgMM 0005.06 trans-4-Aminocyclohexanol Hydrochloride (A) 100 mgMM 0005.07 cis-4-Aminocyclohexanol Hydrochloride (A) 100 mgAmiloride Hydrochloride 鹽酸阿米洛利 2016-88-8 MM 0560.00 Amiloride Hydrochloride Dihydrate (A) 500 mgAminocaproic Acid 6-氨基己酸 60-32-2 MM 0896.00 Aminocaproic Acid (A) 500 mgAmiodarone Hydrochloride 鹽酸胺碘酮 19774-82-4 MM 0697.00 Amiodarone Hydrochloride (A) 250 mgMM 0697.11 Imp. A (EP) as Oxalate: (2-Butylbenzo- (A) 100 mg furan-3-yl)[4-[2-(diethylamino)ethoxy]- phenyl]methanone Oxalate MM 0697.03 Imp. B (EP) as Hydrochloride: (2-Butylbenzo- (D) 100 mg furan-3-yl)[4-[2-(ethylamino)ethoxy]-3,5-diiodo- phenyl]methanone Hydrochloride (Desethyl- amiodarone Hydrochloride) MM 0697.04 Imp. C (EP) as Hydrochloride: (A) 100 mg (2-Butylbenzofuran- 3-yl)[4-[2-(diethylamino)ethoxy]- 3-iodophenyl]methanone Hydrochloride MM 0697.05 Imp. D (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy- (A) 100 mg 3,5-diiodophenyl)methanone MM 0697.06 Imp. E (EP): (2-Butylbenzofuran- (A) 100 mg 3-yl)(4-hydroxyphenyl)methanone MM 0697.07 Imp. F (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy- (A) 100 mg 3-iodophenyl)methanone MM 0697.09 Imp. H (EP) as Hydrochloride: 2-Chloro-N,N-diethylethanamine (C) 100 mg Hydrochloride (2-Chlorotriethylamine Hydrochloride; (2-Chloroethyl)diethylamine Hydrochloride) MM 0697.10 Amiodarone N-Oxide Hydrochloride (A) 100 mgAmisulpride 阿米舒必利 71675-85-9 MM 0051.01 Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine (A) 100 mgAmitraz 雙甲瞇 33089-61-1 MM 1018.01 Imp. A (BP): 2,4-Dimethylaniline (A) 100 mg (2,4-Xylidine) MM 1018.02 Imp. B (BP): Form-2',4'-xylidide (A) 100 mgAmitriptyline Hydrochloride 鹽酸阿米替林 549-18-8 MM 0062.00 Amitriptyline Hydrochloride (A) 500 mgMM 0062.01 Imp. A (EP): 10,11-Dihydro-5H-dibenzo- (B) 100 mg [a,d][7]annulen-5-one (Dibenzosuberone) MM 0062.02 Imp. B (EP) as Hydrochloride: 3-(5H-Dibenzo[a,d][7]annulen- (A) 100 mg 5-ylidene)-N,N-dimethylpropan-1-amine Hydrochloride (Cyclobenzaprine Hydrochloride) MM 0079.00 Imp. C (EP) as Hydrochloride: 3-(10,11-Dihydro-5H- (A) 500 mg dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine Hydrochloride (Nortriptyline Hydrochloride) MM 0062.03 Imp. D (EP): 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H- (A) 100 mg dibenzo[a,d][7]annulen-5-ol MM 0062.05 Imp. F (EP): (5EZ,10RS)-5-[3-(Dimethyl- (A) 100 mg amino)propylidene]-10,11-dihydro-5H- dibenzo[a,d][7]annulen-10-ol MM 0062.14 Imp. G (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ol (A) 100 mg (Dibenzosuberol) MM 0062.12 Amitriptyline N-Oxide Hydrochloride (B) 10 mgMM 0062.13 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene (Dibenzosuberane) (A) 100 mgAmlodipine Besilate 2[(2-氨基乙氧基)甲基]-4(2-)-3-乙氧甲;-5-甲氧甲;-6-甲基-1,4-二氫吡啶苯磺酸鹽 MM 0383.00 Amlodipine Besilate (D) 100 mgMM 0383.06 Amlodipine (A) 100 mgMM 0383.01 Imp. A (EP): 3-Ethyl-5-Methyl (4RS)-4-(2-Chlorophenyl)- (D) 100 mg 2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]- 6-methyl-1,4-dihydropyridine-3,5-dicarboxylate MM 0383.02 Imp. B (EP): 3-Ethyl 5-Methyl (4RS)- (D) 100 mg 4-(2-Chlorophenyl)-6-methyl- 2-[[2-[[2-(methylcarbamoyl)benzoyl]amino]- ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate MM 0383.03 Ethyl Methyl (4RS)-2,6-Bis[(2-aminoethoxy)methyl]- (D) 100 mg 4-(2-chlorophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate Dihydrochloride MM 0383.04 Imp. D (EP): 3-Ethyl-5-Methyl 2-[(2-Aminoethoxy)methyl]- (D) 100 mg 4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate MM 0383.10 ethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylateImp. E (EP): Diethyl (4RS)-2-[(2-Amino- (D) 100 mgMM 0383.07 Imp. G (EP): Dimethyl 4-(2-Chlorophenyl)- (A) 100 mg 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate MM 0383.11 Imp.3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridin-2-yl]methoxy]ethyl]-carbamoyl]benzoicH (EP): 2-[[2-[[(4AcidRS)-4-(2-Chlorophenyl)- (D) 100 mgMM 0383.05 Benzenesulfonic Acid (B) 100 mgAmlodipine Maleate 馬來酸氨氯地平 88150-47-4 MM 0631.00 Amlodipine Maleate (D) 100 mgAmlodipine Mesilate MM 0592.00 Amlodipine Mesilate (D) 100 mgAmodiaquine Dihydrochloride Dihydrate 阿莫地喹鹽酸鹽 6398-98-7 MM 0617.00 Amodiaquine Dihydrochloride Dihydrate (A) 500 mgMM 0617.01 4-Acetamido-2-diethylaminomethylphenol (A) 100 mgMM 0617.02 7-Chloro-4-(4-hydroxyphenylamino)quinoline (A) 100 mgMM0617.03 4,7-Dichloroquinoline (C) 100 mgMM 0617.04 Monodesethylamodiaquine Dihydrochloride (A) 100 mgAmoxicillin Trihydrate 阿莫西林三水物 61336-70-7 MM 0232.00 Amoxicillin Trihydrate (A) 500 mgMM 0026.04 Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia- (B) 100 mg 1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) MM 0232.03 Imp. C (EP): (4S)-2-[5-(4-Hydroxyphenyl)- (A) 100 mg 3,6-dioxopiperazin-2-yl]-5,5-dimethyl-thiazolidine- 4-carboxylic Acid (Amoxicillin Diketopiperazines) MM 0232.04 Imp. D (EP) as Sodium Salt:(4S)-2-[[[(2R)-2-Amino- (A) 100 mg 2-(4-hydroxyphenyl)acetyl]amino]-carboxymethyl]- 5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (Penicilloic Acids of Amoxicillin Sodium Salt) MM 0232.05 Imp. E (EP): (2RS,4S)-2-[[[(2R)-2-Amino- (A) 50 mg 2-(4-hydroxyphenyl)acetyl]amino]methyl]- 5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Amoxicillin) MM 0232.06 Imp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol (A) 100 mgMM 0232.08 Imp. H (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2- (A) 100 mg (4-hydroxyphenyl)acetic Acid MM 0232.09 Imp. I (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid (B) 100 mgMM 0232.12 (2R)-2-Amino-2-(4-hydroxyphenyl)acetamide (A) 100 mgAmpicillin Sodium 氨芐西林鈉 69-52-3 MM 0253.00 Ampicillin Sodium (A) 500 mgMM0253.15 Ampicillin Trihydrate (A) 500 mgMM 0026.04 Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia- (B) 100 mg 1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) MM 0253.02 Imp. B (EP): (2S,5R,6R)-6-[[(2S)-2-Amino- (A) 100 mg 2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia- 1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (L-Ampicillin) MM 0253.03 Imp. C (EP): (4S)-2-(3,6-Dioxo-5-phenylpiperazin-2-yl)- (A) 100 mg 5,5-dimethylthiazolidine-4-carboxylic Acid (Diketopiperazines of Ampicillin) MM 0253.04 Imp. D (EP) as Sodium Salt: (4S)-2-[[[(2R)-2-Amino- (A) 100 mg 2-phenylacetyl]amino]-carboxymethyl]- 5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt MM 0253.06 Imp. F (EP): (2RS,4S)-2-[[[(2R)-2-Amino- (A) 100 mg 2-phenylacetyl]amino]methyl]-5,5-dimethyl-thiazolidine- 4-carboxylic Acid (Penilloic Acids of Ampicillin) MM 0253.11 Imp. K (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic (A) 100 mg Acid MM 0253.08 Imp. H (EP): 3-Phenylpyrazin-2-ol (A) 100 mgMM 0253.12 Imp. L (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) (B) 100 mgMM 0253.16 Ampicillin, anhydrous (A) 500 mgAndrostanolone 雄諾龍 521-18-6 MM 0565.00 Androstanolone (A) 250 mgAnise Oil MM 0164.01 trans-Anethole (C) 100 mgMM 0164.02 Estragole (C) 100 mgMM 0164.03 Anisaldehyde (C) 100 mgMM 0164.05 Linalol (C) 100 mgMM 0164.06 cis-Anethole (D) 100 mgAntazoline Hydrochloride 鹽酸安他唑啉 2508-72-7 MM 0171.00 Antazoline Hydrochloride (A) 500 mgMM 0171.01 Imp. A (EP) as Dihydrochloride: N-(2-Aminoethyl)- (A) 100 mg 2-(benzylphenylamino)acetamide Dihydrochloride N MM 0171.03 N-Benzylaniline (B) 100 mgMM 0171.04 2-Chloromethyl-4,5-dihydro-1H-imidazole Hydrochloride (A) 100 mgAntazoline Phosphate 安它唑啉磷酸酯 154-68-7 MM 0561.00 Antazoline Phosphate (A) 500 mgApomorphine Hydrochloride MM 0562.00 Apomorphine Hydrochloride Hemihydrate (A) 250 mgMM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate: Morphine (A) 250 mg Hydrochloride Trihydrate [Controlled Substance] Aprindine Hydrochloride 鹽酸茚丙胺 33237-74-0 MM 0467.00 Aprindine Hydrochloride on requestArginine MM 0568.00 Arginine (A) 500 mgArginine Hydrochloride L-精氨酸鹽酸鹽 1119-34-2 MM 0569.00 Arginine Hydrochloride (A) 500 mgArticaine Hydrochloride 鹽酸阿替卡因 23964-57-0 MM 0369.00 Articaine Hydrochloride (A) 100 mgMM 0369.01 Imp. A (EP) as Hydrochloride: Methyl (A) 100 mg 3-[[2-(Propylamino)acetyl]amino]-4-methylthiophene- 2-carboxylate Hydrochloride (Acetamidoarticaine Hydrochloride) MM 0369.02 Imp. B (EP) as Hydrochloride: 4-Methyl-3-[[(2RS)- (A) 50 mg 2-(propylamino)propanoyl]amino]thiophene-2-carboxylic Acid Hydrochloride (Articaine Acid Hydrochloride) MM 0369.03 Imp. C (EP) as Hydrochloride: 1-Methylethyl 4-Methyl- (A) 100 mg 3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene- 2-carboxylate Hydrochloride (Articaine Isopropyl Ester Hydrochloride) MM 0369.04 Imp. D (EP) as Hydrochloride: Methyl 3-[[(2RS)- (B) 10 mg 2-(Ethylamino)propanoyl]amino]-4-methylthiophene- 2-carboxylate Hydrochloride (Ethylarticaine Hydrochloride) MM 0369.05 Imp. E (EP) as Hydrochloride: Methyl 4-Methyl-3-[[(2RS)- (A) 100 mg 2-[(1-methylethyl)amino]propanoyl]amino]thiophene- 2-carboxylate Hydrochloride (Isopropylarticaine Hydrochloride) MM 0369.06 Imp. F (EP) as Hydrochloride: 4-Methyl-N-propyl- (A) 50 mg 3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene- 2-carboxamide Hydrochloride (Articaine Acid Propionamide Hydrochloride) MM 0369.07 Imp. G (EP) as Hydrochloride: Methyl 3-[[(2RS)- (A) 100 mg 2-(Butylamino)propanoyl]amino]-4-methylthiophene- 2-carboxylate Hydrochloride (Butylarticaine Hydrochloride) MM 0369.08 Imp. H (EP) as Hydrochloride: Methyl 3-[[(2RS)- (A) 100 mg 2-(Dipropylamino)propanoyl]amino]-4-methylthiophene- 2-carboxylate Hydrochloride (Dipropylarticaine Hydrochloride) MM 0369.09 Imp. I (EP): Methyl 3-Amino-4-methylthiophene-2-carboxylate (C) 100 mg (3-Aminoarticaine) MM 0369.10 Imp.4-methylthiophene-2-carboxylateJ (EP): Methyl 3-[[(2RS)-2-Bromopropanoyl]amino]-(Bromo Compound) (B) 10 mgAscorbic Acid MM 0166.00 L-Ascorbic Acid (A) 500 mgAsparagine Monohydrate L-天冬酰胺一水物 5794-13-8 MM 0765.01 Phenylacetylasparagine (C) 50 mgAspartame 阿斯巴甜 22839-47-0 MM 0314.00 Aspartame (A) 500 mgMM 0314.01 Imp. A (EP): 2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid (A) 100 mg (Diketopiperazine) MM 0314.02 Imp. B (EP): L-Aspartyl-L-phenylalanine (A) 100 mgMM 0314.03 Imp. C (EP): Phenylalanine (B) 100 mgAspartic Acid MM 0567.00 Aspartic Acid (A) 500 mgAstemizole 阿司咪唑 68844-77-9 MM 0184.00 Astemizole (A) 250 mgMM 0184.13 Desmethyl Astemizole Hydrochloride (B) 10 mgAtenolol 阿替洛爾 29122-68-7 MM 0013.00 Atenolol (A) 500 mgMM 0013.03 Imp. A (EP): 2-(4-Hydroxyphenyl)acetamide (B) 100 mgMM 0013.05 Imp.2,3-Dihydroxypropoxy)phenyl]acetamideB (EP): 2-[4-[(2RS)- (A) 100 mgMM 0013.01 2-[4-[[(2RS)-Oxiran-2-yl]methoxy]phenyl]acetamide (A) 100 mgMM 0013.06 Imp.2-hydroxypropoxy]phenyl]acetamideD (EP): 2-[4-[(2RS)-3-Chloro- (A) 50 mgMM 0013.07 Imp.diyl)bis(oxy-4,1-phenylene)]diacetamideE (EP): 2,2'-[(2-Hydroxypropane-1,3- (A) 50 mgMM 0013.02 Imp F (EP): 2,2'-[[(1-Methylethyl)imino]- (A) 50 mg bis[(2-hydroxypropane-3,1-diyl)oxy- 4,1-phenylene]]diacetamide MM 0013.04 Imp. G (EP): 2-[4-[(2RS)-2-Hydroxy- (A) 50 mg 3-[(1-methylethyl)amino]propoxy]phenyl]acetic Acid MM 0013.08 Imp. H (EP): 2-[4-[(2RS)-2-Hydroxy- (A) 100 mg 3-[(1-methylethyl)amino]propoxy]phenyl]acetonitrile MM 0013.13 4-Hydroxyphenylacetic Acid (B) 100 mgAtorvastatin Calcium 阿托伐他汀鈣 134523-03-8 MM 0400.00 Atorvastatin Calcium (D) 100 mgMM 0400.12 Imp. G (Pharmeuropa) as Calcium Salt: (D) 100 mg (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4- (phenylcarbamoyl)-5-(propan-2-yl)-1pyrrol-1-yl]-5-hydroxy-3-methoxyheptanoicH- Acid Calcium Salt (3-O-Methylatorvastatin Calcium Salt) MM 0400.16 Imp. G (Pharmeuropa) as Lithium Salt: (3R,5R)-7- (D) 100 mg [2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)- 5-(propan-2-yl)-1heptanoic Acid LithiumH-pyrrol-1-yl]-5-hydroxy-3-methoxy-Salt (3-O-Methylatorvastatin Lithium Salt) MM 0400.01 Imp. H (Pharmeuropa): (2R,4R)-2-[2-[2-(4-Fluoro- (D) 100 mg phenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan- 2-yl)-1pyran-6-oneH-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2(Atorvastatin Lactone) H- MM 0400.04 1,1-Dimethylethyl (4R-cis)- (A) 100 mg 6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1-H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate MM 0400.05 1,1-Dimethylethyl (4R-cis)-6-Aminoethyl-2,2-dimethyl- (A) 100 mg 1,3-dioxane-4-acetate MM 0400.13 1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]-ethyl]- (A) 100 mg 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H- pyrrole-3-carboxamide (Atorvastatin eliminated Lactone) Atracurium Besilate 苯磺酸阿曲庫銨 64228-81-5 MM 0858.13 Imp. J (EP): Methyl Benzenesulphonate (A) 100 mgAtropine 阿托品 51-55-8 MM 0289.18 Atropine (A) 250 mgMM 0289.00 Atropine Sulphate (A) 500 mgMM 0289.01 Imp.8-azabicyclo[3.2.1]oct-3-ylHydrochlorideA (EP) as Hydrochloride:2-Phenylpropenoate(1R,3r,5S)-8-Methyl- (D) 100 mg (Apoatropine Hydrochloride) MM 0601.03 Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) (A) 100 mgMM 0546.00 Imp.HydrobromideF (EP) asTrihydrateHydrobromide Trihydrate: Hyoscine (A) 500 mgMM 0289.03 Atropic Acid (A) 100 mgAvobenzone 阿伏苯宗 70356-09-1 MM 0902.00 Avobenzone (A) 500 mgAzelaic Acid 壬二酸 123-99-9 MM 0687.00 Azelaic Acid (A) 500 mgAzelastine Hydrochloride 鹽酸氮卓斯汀 79307-93-0 MM 0362.00 Azelastine Hydrochloride (A) 100 mgMM 0362.04 Imp. A (EP): (C) 100 mgMM 0362.02 Imp.1-methylhexahydro-1H-azepin-4-yl]diazaneB (EP) as Hydrochloride: 1-Benzoyl-2-[(4RS)-Hydrochloride (A) 100 mgMM 0362.05 Imp. C (EP): 2-[(4-Chlorophenyl)acetyl]benzoic Acid (A) 100 mgMM 0362.01 Imp. D (EP): 4-(4-Chlorobenzyl)phthalazin-1(2H)-one (A) 100 mgMM 0362.06 Imp. E (EP) Z-Isomer: (Z)-3-(4-Chlorobenzylidene)- (A) 100 mg isobenzofuran-1(3H)-one MM 0362.03 1-Methylazepan-4-one Hydrochloride (A) 100 mgAzithromycin 阿奇霉素 83905-01-5 MM 1075.01 Imp. A (EP): 6-Demethylazithromycin (D) 100 mg (Azaerythromycin A)
廣州優(yōu)瓦儀器有限公司給您提供質(zhì)的儀器耗材咨詢服務(wù),歡迎隨時(shí)與我司聯(lián)系。聯(lián)系方式:www.uwalab.com陳志東QQ:7184896czdchen@163.com
上海仁彩自動(dòng)化科技有限公司 |
聯(lián)系人: 楊 波(銷售經(jīng)理) |
手 機(jī):18117260919 |
Q Q:3273584470 |
傳 真: |
地 址:上海市金山區(qū)楓涇鎮(zhèn)新涇路59號(hào) |
歡迎來電咨詢訂購!上海仁彩自動(dòng)化科技有限公司將竭誠為您服務(wù)! |
KU-6201泛用塑材接著用光硬化樹脂
Ø 產(chǎn)品簡(jiǎn)介
KU-6201光硬化樹脂,是特別為ABS、HIPS、PS、PC、PVC、壓克力等泛用型塑膠材質(zhì)接著所研發(fā)的產(chǎn)品。本系統(tǒng)黏度極稀,滲透性佳,薄層接著樹脂透明澄清,在紫外光或可見光燈源的照射下,樹脂迅速發(fā)生反應(yīng),能與基材合為一體,產(chǎn)生極優(yōu)良的接著強(qiáng)度。特別是抗紫外線的壓克力、PC等材質(zhì)應(yīng)用方面,KU-6201硬化後的接著強(qiáng)度甚至超過原來的材質(zhì),是相當(dāng)可靠的光硬化樹脂。
Ø 產(chǎn)品特色
KU-6201
(1)高滲透性,具有強(qiáng)韌、吸震和耐冷熱衝擊等性質(zhì)。
(2)可與基材本身反應(yīng)產(chǎn)生鍵結(jié),發(fā)揮高強(qiáng)度的接著力。
(3)能夠適用於多種塑膠材質(zhì),廣泛解決塑膠接著的困難,耐酸堿。KU-6205塑膠,TPU,金屬披覆用光硬化樹脂
Ø 產(chǎn)品簡(jiǎn)介
KU-6205是針對(duì)玻璃PVC,ABS,PCB電鍍對(duì)金屬(鋁,鐵,銅, 金屬焊點(diǎn)補(bǔ)強(qiáng),不鏽鋼),TPU的披覆研發(fā)的。KU-6205具有高透明度,快速硬化,完全無色透明性質(zhì),最適合電子業(yè)封裝快速生產(chǎn)。
Ø 產(chǎn)品特色
KU-6205
(1)適用於多種塑材接著。
(2)具有柔軟性,可吸收破壞能量。
|
|
汕頭市中發(fā)模塊商行位于汕頭市粵東電子城,專業(yè)經(jīng)營日本、美國、歐洲及世界各名廠(三菱、東芝、富士、西門子、西門康、三社、歐派克、三肯、ABB、IR、APT、ST、美國VICOR、朗訊(LUCENT)、騰訊(ARTESYN)、DATEL、雅達(dá)(ASTEC)、POWER-ONE(IPD)和日本LAMBDA、 COSEL、愛立信(ERICSSON)……)生產(chǎn)的IGBT、IPM、PIM、場(chǎng)效應(yīng)、達(dá)林頓、肖特基、快恢復(fù)、可控硅、三相橋、DC/DC、AC/AC等功率模塊與電源模塊. 自2000年創(chuàng)業(yè)以來,我們以“顧客至上,信譽(yù),質(zhì)優(yōu)價(jià)廉,交貨快捷"為宗旨,竭誠為廣大客戶提供質(zhì)的服務(wù)。本商行現(xiàn)已是一家較大的模塊零售批發(fā)商,擁有多年的銷售經(jīng)驗(yàn),實(shí)力雄厚,在業(yè)界享有良好的口碑,并備有大量現(xiàn)貨庫存,質(zhì)量,價(jià)格優(yōu)惠.歡迎廣大的新老顧客前來洽談合作,我們一定努力做到,成為您的合作伙伴!
TEL:0754-84495025 FAX:0754-84495025 手機(jī):15992241433 聯(lián)系人:柯先生
本系列電磁失電制動(dòng)器是通電電磁吸合,斷電時(shí),彈簧加壓,實(shí)現(xiàn)摩擦制動(dòng),主要與Y系列電機(jī)配套成YEJ系列電磁制動(dòng)三相異步電機(jī)。適用于冶金,建筑,化工,食品,機(jī)床,包裝,舞臺(tái),電梯,輪船等機(jī)械中,實(shí)現(xiàn)快速停車,定位準(zhǔn)確,安全制動(dòng)等目的。
使用條件
本系列制動(dòng)器在下列條件下能可靠的工作
1.海拔高度不超過2000米,空氣相對(duì)濕度不超過85%;
2.周圍介質(zhì)中,無足以腐蝕金屬和破壞絕緣的氣體和塵埃;
3.工作環(huán)境溫度-5~+40℃,摩擦片表面不得有油污;
4.絕緣等級(jí)為B級(jí),防護(hù)等級(jí)為IP23,電壓波動(dòng)范圍不超過+5%和-15%;
5.工作氣隙不得超過最大工作氣隙;
6.安裝方式:軸向水平安裝,軸向垂直安裝;
7.工作方式:間歇式工作,連續(xù)式工作。
產(chǎn)品結(jié)構(gòu)和工作原理
該系列制動(dòng)器由磁軛體,勵(lì)磁線圈、彈簧、制動(dòng)盤、銜鐵、花鍵套、手動(dòng)釋放裝置等組成。安裝于電機(jī)后端蓋上(或設(shè)備的法蘭盤上),調(diào)整安裝螺釘使氣隙到規(guī)定值;花鍵套固定于軸上,制動(dòng)盤在花鍵套上可軸向滑動(dòng),制動(dòng)時(shí)產(chǎn)生制動(dòng)力矩。
當(dāng)制動(dòng)器的線圈通電時(shí),線圈產(chǎn)生磁場(chǎng),銜鐵被磁力吸向磁軛,銜鐵與制動(dòng)盤脫開,此時(shí)制動(dòng)盤被電機(jī)軸帶著正常轉(zhuǎn)動(dòng);當(dāng)線圈斷電時(shí),磁場(chǎng)消失,銜鐵被彈簧的作用力推向制動(dòng)盤,產(chǎn)生摩擦扭矩而制動(dòng)。
扳動(dòng)“手動(dòng)釋放裝置”或擰緊“螺釘釋放裝置”,也可使銜鐵釋放,方便設(shè)備的安裝和調(diào)節(jié)。